Inconsistency of the published definition of ocular hypertension

Journal of Glaucoma

Volumn 15, Issue 6, 2006, Pages 529-533

  Tavares, Ivan M ^a   Medeiros, Felipe A ^a   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intraocular pressure; Ocular hypertension; Systematic review

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; LATANOPROST;

CLINICAL TRIAL; CORNEA THICKNESS; CRITERION VARIABLE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPTIC DISK; PRIORITY JOURNAL; PUBLICATION; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; TONOMETRY; VISUAL FIELD;

HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE DISEASES; TERMINOLOGY; TONOMETRY, OCULAR; VISION DISORDERS; VISUAL FIELDS;

EID: 33751028320     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000212279.03595.70     Document Type: Review

References (16)

1. Lee BL, Bathija R, Weinreb RN. The definition of normal-tension glaucoma. J Glaucoma. 1998;7:366-371.
2. Bathija R, Gupta N, Zangwill L, et al. Changing definition of glaucoma. J Glaucoma. 1998;7:165-169.
3. Gordon MO, Kass MA, and for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants. Arch Ophthalmol. 1999;117:573-583.
4. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873-890.
5. Simmons ST, Earl ML. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering. Ophthalmology. 2002;109:307-314; Discussion 314-305.
6. Brandt JD, Beiser JA, Kass MA, et al. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108:1779-1788.
7. Copt R-P, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999;117:14-16.
8. Herman DC, Hodge DO, Bourne WM. Increased corneal thickness in patients with ocular hypertension. Arch Ophthalmol. 2001;119:334-336.
9. Medeiros FA, Sample PA, Weinreb RN. Corneal thickness measurements and visual function abnormalities in ocular hypertensive patients. Am J Ophthalmol. 2003;135:131-137.
10. Medeiros FA, Sample PA, Weinreb RN. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes. Ophthalmology. 2003;110:1903-1908.
11. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720; Discussion 829-730.
12. Brandt JD, Beiser JA, Gordon MO, et al. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004;138:717-722.
13. Miglior S, Guareschi M, Romanazzi F, et al. The impact of definition of primary open-angle glaucoma on the cross-sectional assessment of diagnostic validity of Heidelberg retinal tomography. Am J Ophthalmol. 2005;139:878-887.
14. Coleman AL, Sommer A, Enger C, et al. Interobserver and intraobserver variability in the detection of glaucomatous progression of the optic disc. J Glaucoma. 1996;5:384-389.
15. Lichter PR. Variability of expert observers in evaluating the optic disc. Trans Am Ophthalmol Soc. 1976;74:532-572.
16. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453-464.